Home › Japanese Regulatory Agency Licenses Certara's Phoenix And Simcyp Software To Support Model-Based Drug Development
 

Keywords :   


Japanese Regulatory Agency Licenses Certara's Phoenix And Simcyp Software To Support Model-Based Drug Development

2015-03-04 04:16:04| drugdiscoveryonline News Articles

Certara, the global biosimulation technology-enabled drug development and drug safety consulting company, recently announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) is equipping its pharmacometrics team with Certara’s Phoenix biosimulation solutions and its Simcyp Population-based Simulator

Tags: support software development japanese

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Lawsuit over FDA's regulatory approval process for carbadox dismissed
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 16
07.11Hurricane Rafael Wind Speed Probabilities Number 16
07.11Hurricane Rafael Forecast Advisory Number 16
07.11Hurricane Rafael Public Advisory Number 16
07.11Summary for Hurricane Rafael (AT3/AL182024)
07.11Tropical Depression Fourteen-E Graphics
More »